RX-0047

N/A

Report date: 2022/11/17 15:42:31
NME

Base Information

Drug NameRX-0047
Drug Alias NameMyHIFRX-0047WGI-0047
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA interference
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRexahn Pharmaceuticals IncZhejiang Haichang Biopharmaceuticals Co LtdOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Haichang Biopharmaceuticals Co LtdRexahn Pharmaceuticals IncOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A